We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleASX health stocks fall 2.15% in past five days, while broader market down 1.42% MedAdvisor drops 3...
Read ArticleNyrada to launch phase I first-in-human trial after passing preclinical safety studies Neuren Pharm...
Read ArticleDespite the stunning advances in medical science – keyhole and robotic surgery and the like – the se...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleASX health stocks rise 0.9% in past five days as broader markets lift 1.2%, despite Friday selloff...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleMicro-X embarking on ‘biggest advancement in X-ray since its invention’ in 1895 Its X-ray technolog...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX tech sector falls 3.87% in April, but still outpaces broader markets YTD with a 19.55% rise Ric...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleBy Tim Boreham, Editor ASX code: ((HYD)) Market cap: $4.3m Shares on issue: 254,218,847 Financials (...
Read ArticleLocal markets get smashed, drop 1.8pc All 11 ASX sectors down Small Caps led by Task Group A r...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((4DX)) - 4DMedical ((APM)) - A...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleASX medical devices to make inroads with FDA after a good year for drug developers FDA is reviewing...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleQuarterly earnings season is underway, and we’ve picked three highlights from the ASX Healthcare sec...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleASX health sector falls in line with broader markets as macroeconomic factors continue to create un...
Read ArticleInnovative X-ray technology specialist Micro-X (ASX: MX1) has been awarded a significant $1.5 millio...
Read ArticleFutures suggest the ASX will open slightly lower this morning as investors await the US Fed interest...
Read ArticleASX to track Wall Street and open lower Instacart jumped by 12pc on Nasdaq IPO debut A look at how...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((AIM)) - Ai...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleMedical devices offer faster route to commercialisation than drugs How newly listed Curvebeam AI ai...
Read ArticleStroke has long been recognised as being among Australia’s most costly disease groups. It occurs wh...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleASX health stocks up 1% in the past five days in line with broader markets Volpara records third qu...
Read ArticleLawyers for descendants of the late Peter Wright were first on the stand today, taking on Gina Rineh...
Read ArticleMicro-X shares were up by 28.57% after the announcement today of the extension of its contract with...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] South Australian x-ray tech...
Read ArticleAt noon, the S&P/ASX 200 is 0.14 per cent higher at 7,324. Suncorp has confirmed that the Austra...
Read ArticleMicro-X (ASX:MX1) extends contract with U.S. DHS to test self-screening modules at an airport. In...
Read Article24 Jul 2023 - A snapshot of the stocks on the move, featuring Micro-X (ASX:MX1), European Metals (AS...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX health stocks have fallen in the past five days in line with broader markets Mach7 wins a US$60...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleThe ASX tech sector rallied 11.6% in May and is up 16.94% YTD, surpassing the S&P ASX 200 Audio...
Read ArticleASX health stocks outperforming the broader market but remain flattish for week Several ASX health...
Read ArticleThe ASX200 shed 8.1 points on Tuesday or 0.11 per cent, just one day after its strongest advance sin...
Read ArticleASX benchmark ends the day flat, but not for lack of trying to rise. Or fall Tech stocks fell hard...
Read ArticleMicro-X Argus bomb detection unit successfully field tested opening door to US$1.8 billion market T...
Read ArticleASX health stocks fall 0.8% in the past five days in line with broader markets following latest rat...
Read ArticleRBA Board kicks the nation in the goolies again, demanding another 25 basis points Investors seemin...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleWhat’s wrong with our tadpoles, gentlemen? According to local fertility expert Prof John Aitken, spe...
Read ArticleASX health stocks fall 0.9% in the past five days Healius receives a $1.52 billion takeover offer f...
Read ArticleThe medical imaging market size globally is forecast to reach $68.8 Billion by 2030 Several ASX hea...
Read ArticleASX climbed as high as +1.3%, easing slightly to close up 0.9%. XEC Emerging Companies and Goldies...
Read ArticleASX health stocks fall 1.87% in the past five days as reporting season ends Healius moves to a stat...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((ABY)) - Adore Beauty ((AIM))...
Read ArticleASX health stocks rise 2.27% this week after finishing up 3.9% in January in strong start to 2023...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleThe ASX Health sector has fallen ~1.5% in its first trading week of 2023 Mach7 has surged after la...
Read ArticleThe long and short of 2022 is that it was a frustrating period for the Australian biotech sector but...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleIt’s quarterlies season again as the ASX market announcements page becomes increasingly flooded with...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleShareCafeWebinar Recap – EZZ, ELS, MX1 & QXR Catch up on the full webinar presentations from EZ...
Read ArticleShareCafeMicro-X (ASX: MX1) – Webinar Presentation Peter Rowland – Managing Director – Mirco-X is a...
Read ArticleThe ASX will open more than 1% lower on Monday Wall Street tumbled again on Friday on recession fea...
Read ArticleShareCafeEvening Report: 19 September, 2022 by Paul Sanger At the closing bell, the S&P/ASX 20...
Read ArticleThe Micro-X Ltd (ASX: MX1) share price exploded today on news of a $15 million investment. Micro-X...
Read ArticleThe ASX 200 is vacillating Small caps are down over 1.3% Demetallica is a great name and it’s up 40...
Read ArticleShareCafeLunch Report: 19 September, 2022 by Paul Sanger At noon, the S&P/ASX 200 is 0.10 per...
Read ArticleShareCafeStocks of the Hour: 19 September, 2022 Australian hi-tech company...
Read Article19 Sep 2022 - A snapshot of the stocks on the move featuring Micro-X (ASX:MX1), IVE Group (ASX:IGL)...
Read ArticleASX 200 sinks 2% Small caps get crushed, down 2.5% Region, AUD and miners sink on weaker China act...
Read ArticleThe RangeHawk drone has a whopping 40m wingspan and is set to test hypersonic weapons DroneShield...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((AMS)) - Atomos ((ATA)) - Attu...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read Article114 tech stocks were trading down for the month of June 11 stocks flatlined and only 22 were in the...
Read ArticleAvita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is pop...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleGoogle engineer reckons chatbot has become sentient Xtek sends $9.5m of specialist ballistic produc...
Read ArticleDark clouds continue to hover over ASX health stocks Health imaging company Volpara’s FY22 results...
Read ArticleSuccessful first stage design milestone for Micro-X Passenger Self screening station – Unlocks $0.7m...
Read ArticleHealthcare and life sciences expert Scott Power – a senior analyst with Morgans Financial for 24 yea...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleASX gives back early gains on Wednesday Small caps whacked as Fed Hawks get hawky, bonds get toppy,...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleShareCafeWebinar Recap – MX1, SPL, MAP, RFL & RAP Catch up on the full webinar with presentatio...
Read ArticleShareCafeMicro-X (ASX: MX1) – Webinar Presentation Peter Rowland – MD – Micro-X Limited designs, de...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleThe ASX Emerging Companies Index (XEC) has ended 1.5% higher on Wednesday, driven by a new EV car as...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleLinius pursues commercialisation of video virtualisation engine tech UBI up after nabbing new distr...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAs well as covering large caps, many brokers also cover smaller companies. In light of this, I thou...
Read ArticleLocal stocks closed in the red on Wednesday (as expected), after US stocks posted their biggest fall...
Read ArticleThe ASX 200 closed 1% higher at 7,370 points, a level that saw it nearly recoup losses made earlier...
Read ArticleLeader of the ASX health stocks today is Imugene (ASX:IMU) up 4.11% after announcing plans to presen...
Read ArticleIt was another day of gains for the ASX led by the energy sector. The ASX 200 rose by 0.116% to clos...
Read ArticleShareCafeHidden Gems Webinar Recap – Perpetual, OLL, FCT, LBT & MX1 Catch up on the full webina...
Read ArticleShareCafeMiniaturising X-Ray Peter Rowland – Managing Director – Micro-X Ltd is an award-winning AS...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((AFG)) - Australian Finance Gr...
Read ArticleHighlights Low interest rate scenario is conducive for growth stocks. The technology sector has...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleTrading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers a...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleWe’ve all heard the maxim that ‘time is money’, but in the case of stroke victims ‘time is brain’. F...
Read ArticleIt wasn’t a happy start to the new financial year for Australia’s bourse, which lost nearly two thir...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticlePeter Rowland, Managing Director of Micro-X (MX1) explains the significance of the next generation X...
Read ArticleThe diagnostics imaging industry has come a long way since the days of X-rays and CT scans – two tec...
Read ArticleSeaTac chosen for Micro-X Inc’s USA headquartersOfficial Opening at 10 am PDT, Friday May 28855 S 19...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleLarge and small caps had diverging fates on the ASX today with the former closing 0.32 per cent down...
Read ArticleWall Street edges lower All major US indices fell overnight, as new US home sales slid by more than...
Read ArticleThe market looks caught in a fairly tight trading band since April as bulls and bears look to see w...
Read ArticleIf you want to know which ASX stocks fund managers and famous investors are putting their money into...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleFor all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t chang...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the fir...
Read ArticleShareCafeHidden Gems Webinar Recap – PFG, EXL, MX1, BRU Catch up on the full webinar with a keynote...
Read ArticleShareCafeMicro-X (ASX: MX1) – Hidden Gems Webinar Presentation Presenter – Peter Rowland – Managing...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleThe ASX had a positive day today gaining 0.8 per cent and all sectors finished in the green except r...
Read Article2021 is set to be another big year for ASX capital raisings with solid volumes so far in 2021. In th...
Read ArticleSource: OSABEE ,Shutterstock Summary Micro-X received MRFF funding for lightweight brain CT sca...
Read ArticleMicro-X (ASX:MX1) shares have hit a more than three-year high after the Brisbane-based portable imag...
Read ArticleMicro-X has received funding commitments of $30.5 million to help expand its US footprint and fast-t...
Read ArticleOn Stockhead today, Which ASX small cap IPOs were the best gainers in 2020? and, Which US stocks sta...
Read ArticleASX-listed x-ray products maker Micro-X has landed in front of small cap fund managers, seeking a ca...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleFor smug non-Croweaters who claim the closest Adelaide has got to technical innovation is a pie floa...
Read ArticleIt’s been another positive day on the ASX in the wake of Democrats gaining control of the US Senate...
Read Article08 Jan 2021 - X-ray tech company, Micro-X (ASX:MX1) has secured a research and development tax incen...
Read ArticleThe US Government’s Department of Homeland Security has selected Micro-X (ASX: MX1) to develop the i...
Read ArticleThe Quickstep Holdings Limited (ASX: QHL) share price is shooting higher today following the releas...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((AMS)...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe COVID-19 pandemic left a lot of medical device companies scrambling to keep up with the unpreced...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleNew research indicates Imagion Biosystems’ (ASX: IBX) imaging particles could bring down Tesla — in...
Read ArticleAustralian x-ray products manufacturer Micro-X Ltd [ASX:MX1] has had its share price open higher tod...
Read ArticleAustralian technology company Micro-X (ASX: MX1) has obtained early approval from the United States...
Read ArticlePortable x-ray manufacturer Micro-X (ASX:MX1) has announced its Rover product has been given FDA 510...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleBell Financial Group (ASX:BFG) is expecting to book a higher $23.5m first-half profit, but investors...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleSince restrictions on elective surgery were lifted, some stocks in the elective surgery space have s...
Read ArticleThe past fortnight has seen another interesting list of buyers and sellers. Angel Seafood (ASX:AS1)...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve bee...
Read ArticleParticipating in small cap raises is proving lucrative for investors, with shares in 47 small caps t...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticlePre-revenue biotech and medtech companies are still not eligible for the Jobkeeper wage subsidy acco...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve kee...
Read ArticleIt’s still a relatively difficult market to raise capital in, particularly at the junior end, but th...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleMorgans Senior Analyst Scott Power updates the network with information on 3 companies: Volpara (ASX...
Read ArticleListed X-ray technology company Micro-X Ltd was in the market on Wednesday, seeking $15 million of n...
Read ArticleMicro-X Ltd (ASX: MX1), an Australian hi-tech company, on 7 April 2020, announced to have received p...
Read ArticleX-ray technology company Micro-X (ASX: MX1) has posted stronger-than-expected first quarter results...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleCoronavirus continues to drive sales into Asia and Europe for South Australian hi-tech x-ray manufac...
Read ArticleAs with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time atta...
Read ArticleMicro-X (ASX: MX1) has collared an additional $1 million in sales for its mobile x-ray technology as...
Read ArticleNeuroscience tech company Cogstate (ASX:CGS) produced some much needed good news today, saying it ha...
Read ArticleYou don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the...
Read ArticleDid you know that a hard-working stallion ejaculates 100 times more sperm than the average bloke? Gi...
Read ArticleStockbroker Morgans is expected to close the books on an equity raising for lightweight X-ray produc...
Read ArticleAustralian high-tech company Micro-X Ltd (ASX: MX1) has informed that it is amending the Convertible...
Read ArticleIn Australia, there are plenty of high-quality health care companies, most of which have delivered e...
Read ArticlePeople in Sydney and Melbourne might think of Adelaide as home to little more than football, wines a...
Read ArticleZelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results f...
Read ArticleQueenstown is known as the adventure capital of the world. It attracts over three million people per...
Read ArticleBusiness magnate Warren Buffet advised the investors to absolutely refrain from investing in a busin...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
